[mp3-jplayer tracks=”CounterSpin Dean Baker Brandon Garrett @https://eadn-wc04-3257648.nxedge.io/audio/counterspin/CounterSpin150925.mp3″]
This week on CounterSpin: Drug company CEO Martin Shkreli became the target of public outrage not just by raising the price of Daraprim, a treatment for toxoplasmosis, from $13 to $750 a tablet–but for being such a jerk about it, telling critics they were “morons” for not understanding his greed-is-actually-altruism philosophy. Shkreli now says he’ll discount the price, but that shouldn’t end public concern about pharmaceutical costs. We’ll talk about the bigger picture with economist Dean Baker of the Center for Economic and Policy Research.
[mp3-jplayer tracks=”CounterSpin Dean Baker @https://eadn-wc04-3257648.nxedge.io/audio/counterspin/CounterSpin150925-DeanBaker.mp3″]
Also on the show: Volkswagen CEO Martin Winterkorn has resigned in the wake of revelations that the company jiggered its diesel cars to trick emissions testing. The case raises yet again the question of whether our legal system can adequately respond to corporate crime. We’ll discuss that issue with Brandon Garrett, professor at the University of Virginia School of Law and author of the book Too Big To Jail: How Prosecutors Compromise With Corporations.
[mp3-jplayer tracks=”CounterSpin Brandon Garrett @https://eadn-wc04-3257648.nxedge.io/audio/counterspin/CounterSpin150925-BrandonGarrett.mp3″]
And first, as usual, we take a quick look back at the week’s press, including money in politics, Hillary Clinton and Planned Parenthood.
[mp3-jplayer tracks=”CounterSpin Banter @https://eadn-wc04-3257648.nxedge.io/audio/counterspin/CounterSpin150925-Banter.mp3″]
